DC Health now offers the Pre-exposure Prophylaxis (PrEP) Drug Assistance Program (DAP), for insured & uninsured HIV negative residents in the DC metropolitan area who are at high risk of HIV infection and are prescribed Truvada as PrEP. Pre-Exposure Prophylaxis therapy is a biomedical treatment that can reduce the spread of HIV in high risk populations by taking a pill daily to reduce the risk of HIV-1 infection among adult men and women. Truvada was approved in 2012 by the U.S. Food and Drug Administration for HIV prevention.
Limited funding is available. Uninsured applicants should contact Gilead’s Advancing Access Patient Assistance Program at 1-800-226-2056 or GileadAdvancingAccess.com prior to applying.
What do I need to recieve DC PrEP DAP?
- be a DC Metropolitan Area resident
- be HIV negative
- Having Insurance is preferred
- Have risk factors for contracting HIV
- Have income at or below 500% of the Federal Poverty Level (FPL)
Questions about PrEP and PrEP DAP?
If you have questions about PrEP, contact your prescribing medical provider or the DC Pharmacy Benefits Program about your PrEP treatment. PrEP-DAP questions?
- Call 202-671-4815
- Fax: 202-673-4365
- Participating DC PrEP DAP Pharmacies
- Click here for DC PrEP DAP Fact Sheet
Useful Information about PrEP